NCT06658652View on ClinicalTrials.gov

The Effect of Food and Water Volume in Healthy Adult Participants Administered Enlicitide Decanoate (MK-0616) (MK-0616-022)

PHASE1CompletedINTERVENTIONAL

Enrollment

34

Participants

Timeline

Start Date

October 24, 2023

Primary Completion Date

December 26, 2023

Study Completion Date

December 26, 2023

Conditions

Healthy

Interventions

DRUG

Enlicitide decanoate

Oral tablet

Trial Locations (1)

68502

Celerion (Site 0001), Lincoln

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY